Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Versus Triple Hyaluronic Acid Injections in Knee Osteoarthritis
NCT07352540Phase 3Active, not recruiting
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Jan 2026
- Primary completion
- Aug 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in osteoarthritis (OA) (2 arms), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index total score at 24 weeks. Started Jan 2026; status: active, not recruiting.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07352540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07352540.